Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -95.65%342.05M | ---- | -26.37%7.87B | ---- | -56.62%10.69B | ---- | 45.32%24.64B | ---- | -38.37%16.96B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -17.00%-4.13B | ---- | -267.74%-3.53B | ---- | 22.81%-960.88M | ---- | -13.10%-1.24B | ---- | 7.30%-1.1B |
| Interest expense - adjustment | ---- | 5.42%12.72B | ---- | 15.28%12.06B | ---- | 9.91%10.46B | ---- | 0.18%9.52B | ---- | -3.73%9.5B |
| Dividend (income)- adjustment | ---- | 4.35%-1.84B | ---- | 51.28%-1.92B | ---- | -8.82%-3.95B | ---- | -0.26%-3.63B | ---- | 3.77%-3.62B |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.31B |
| Attributable subsidiary (profit) loss | ---- | 48.01%-4.97B | ---- | -78.17%-9.56B | ---- | 38.76%-5.36B | ---- | -66.16%-8.76B | ---- | 26.05%-5.27B |
| Impairment and provisions: | ---- | 56.99%4.74B | ---- | -18.11%3.02B | ---- | 54.96%3.69B | ---- | -17.41%2.38B | ---- | 158.56%2.88B |
| -Impairment of property, plant and equipment (reversal) | ---- | 47.32%571.17M | ---- | 437.53%387.71M | ---- | -54.96%72.13M | ---- | 42.84%160.16M | ---- | 35.31%112.13M |
| -Impairmen of inventory (reversal) | ---- | 28.02%300.59M | ---- | -50.26%234.8M | ---- | 12.02%472.05M | ---- | 353.00%421.41M | ---- | 730.82%93.03M |
| -Impairment of trade receivables (reversal) | ---- | 65.53%578.57M | ---- | -45.88%349.52M | ---- | 197.01%645.77M | ---- | -64.21%217.43M | ---- | 170.21%607.57M |
| -Impairment of goodwill | ---- | 1,275.54%1.05B | ---- | -61.42%76.2M | ---- | 14.46%197.51M | ---- | -48.69%172.56M | ---- | 397.68%336.31M |
| -Other impairments and provisions | ---- | 13.72%2.24B | ---- | -14.29%1.97B | ---- | 63.34%2.3B | ---- | -18.72%1.41B | ---- | 137.99%1.73B |
| Revaluation surplus: | ---- | 224.67%3.97B | ---- | 62.50%-3.18B | ---- | 14.69%-8.48B | ---- | -73.79%-9.95B | ---- | -183.02%-5.72B |
| -Fair value of investment properties (increase) | ---- | 108.99%100.14M | ---- | 87.40%-1.11B | ---- | -801.73%-8.84B | ---- | 43.87%-980.71M | ---- | -6.31%-1.75B |
| -Other fair value changes | ---- | 286.98%3.87B | ---- | -676.39%-2.07B | ---- | 104.00%358.82M | ---- | -125.49%-8.97B | ---- | -125.22%-3.98B |
| Asset sale loss (gain): | ---- | -29.78%-4.68B | ---- | -3,146.03%-3.61B | ---- | 98.12%-111.2M | ---- | -77.79%-5.92B | ---- | 77.25%-3.33B |
| -Loss (gain) from sale of subsidiary company | ---- | -124.34%-3.64B | ---- | -305.24%-1.62B | ---- | 114.75%791.44M | ---- | -121.12%-5.36B | ---- | 80.90%-2.43B |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -18.30%-398.09M | ---- | -277.43%-336.5M | ---- | -30.86%-89.16M | ---- | ---68.13M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | 61.05%-642.17M | ---- | -102.66%-1.65B | ---- | -67.18%-813.48M | ---- | 46.13%-486.59M | ---- | 44.31%-903.26M |
| Depreciation and amortization: | ---- | 1.44%10.71B | ---- | 17.21%10.56B | ---- | 13.64%9.01B | ---- | 5.63%7.93B | ---- | 12.03%7.5B |
| -Amortization of intangible assets | ---- | -14.32%2.35B | ---- | 22.31%2.75B | ---- | 20.66%2.25B | ---- | 11.11%1.86B | ---- | 31.16%1.68B |
| -Other depreciation and amortization | ---- | 15.39%694.33M | ---- | 20.25%601.7M | ---- | 35.77%500.4M | ---- | 20.48%368.55M | ---- | -4.23%305.91M |
| Special items | ---- | 68.25%1.56B | ---- | -32.57%925.37M | ---- | 55.10%1.37B | ---- | 128.77%884.83M | ---- | -250.17%-3.08B |
| Operating profit before the change of operating capital | ---- | 45.72%18.41B | ---- | -22.77%12.63B | ---- | 3.13%16.36B | ---- | 18.19%15.86B | ---- | -27.55%13.42B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 2.36%2.54B | ---- | 150.25%2.49B | ---- | -57.13%-4.95B | ---- | 13.46%-3.15B | ---- | -663.65%-3.64B |
| Developing property (increase)decrease | ---- | -64.47%4.05B | ---- | 308.71%11.41B | ---- | 8.30%2.79B | ---- | 162.74%2.58B | ---- | -50.64%-4.11B |
| Accounts receivable (increase)decrease | ---- | -23.86%-4.18B | ---- | 38.28%-3.38B | ---- | -33.22%-5.47B | ---- | -369.24%-4.11B | ---- | 65.88%1.53B |
| Accounts payable increase (decrease) | ---- | 1,566.36%2.22B | ---- | 86.79%-151.26M | ---- | -122.36%-1.15B | ---- | -35.12%5.12B | ---- | 271.98%7.89B |
| Advance payment increase (decrease) | ---- | -78.49%548.95M | ---- | 265.24%2.55B | ---- | -539.06%-1.54B | ---- | 294.62%351.81M | ---- | -75.03%89.15M |
| prepayments (increase)decrease | ---- | -174.74%-874.16M | ---- | 17.98%1.17B | ---- | 121.58%991.43M | ---- | -155.22%-4.59B | ---- | -44.50%-1.8B |
| Derivative financial instruments (increase) decrease | ---- | -163.61%-175.07M | ---- | 127.43%275.22M | ---- | -191.74%-1B | ---- | 468.28%1.09B | ---- | 162.33%192.49M |
| Insurance business receivables (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 105.25%181.95M | ---- | -2,391.50%-3.47B |
| Reinsurance payable Increase (decrease) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.17B | ---- | ---- |
| Buy and sell back financial assets (increase) decrease | ---- | 129.48%2.02B | ---- | ---6.84B | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | 211.25%6.98B | ---- | -390.89%-6.28B | ---- | 121.23%2.16B | ---- | -308.16%-10.16B | ---- | 44.78%4.88B |
| Cash from business operations | 34.45%16.54B | 127.30%31.54B | -28.31%12.3B | 69.52%13.88B | 38.49%17.16B | 309.06%8.19B | 366.36%12.39B | -86.65%2B | -78.27%2.66B | 15.70%14.99B |
| Other taxs | -17.00%-1.93B | -14.91%-4.66B | 17.27%-1.65B | 36.90%-4.05B | 54.77%-1.99B | -20.66%-6.42B | -19.24%-4.41B | 12.74%-5.32B | -20.25%-3.7B | -19.14%-6.1B |
| Net cash from operations | 37.16%14.61B | 173.65%26.88B | -29.77%10.65B | 457.03%9.82B | 90.02%15.16B | 153.10%1.76B | 866.17%7.98B | -137.37%-3.32B | -111.38%-1.04B | 13.45%8.89B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 21.89%475.52M | 27.28%1.15B | 7.54%390.14M | 0.95%901.11M | 3.54%362.78M | -22.38%892.6M | -34.79%350.36M | 16.69%1.15B | 13.61%537.25M | -12.76%985.46M |
| Dividend received - investment | 51.23%4.07B | 14.16%6.34B | 13.24%2.69B | -36.10%5.55B | --2.38B | 54.34%8.69B | ---- | -12.85%5.63B | ---- | 36.35%6.46B |
| Decrease in deposits (increase) | -96.44%67.39M | 1,028.85%2.64B | 251.78%1.89B | 89.47%-284.21M | 154.21%538.55M | -227.75%-2.7B | -130.70%-993.53M | 1,278.72%2.11B | 835.81%3.24B | -111.26%-179.2M |
| Sale of fixed assets | -66.70%1.35B | -23.59%1.17B | 4.19%4.05B | 5.26%1.53B | 286.08%3.88B | 54.68%1.46B | -9.75%1.01B | -10.14%941.79M | 195.81%1.11B | 24.16%1.05B |
| Purchase of fixed assets | 7.11%-4.17B | 22.93%-6.78B | 3.93%-4.49B | -32.28%-8.8B | -8.75%-4.67B | -11.53%-6.65B | -9.76%-4.29B | -4.78%-5.96B | -0.18%-3.91B | -38.96%-5.69B |
| Selling intangible assets | ---- | -28.68%1.03B | ---- | 465.75%1.45B | ---- | -39.89%255.62M | ---- | -8.45%425.26M | ---- | -9.04%464.5M |
| Purchase of intangible assets | ---- | 5.23%-4.07B | -302.05%-134.01M | 7.52%-4.29B | 21.11%-33.33M | -67.05%-4.64B | 78.05%-42.25M | 16.44%-2.78B | -192.07%-192.51M | 21.44%-3.33B |
| Sale of subsidiaries | -9,161.92%-50.5B | -79.03%2.82B | -94.25%557.26M | -26.59%13.44B | 72.09%9.7B | 84.22%18.3B | 69.79%5.63B | 78.56%9.94B | 722.21%3.32B | -16.75%5.56B |
| Acquisition of subsidiaries | -1,053.27%-484.14M | -185.34%-2.72B | 96.38%-41.98M | 29.12%-952.77M | -762.55%-1.16B | 80.59%-1.34B | 119.42%175M | 26.52%-6.92B | -57.32%-900.94M | -9.84%-9.42B |
| Recovery of cash from investments | 19.34%115.58B | 3.62%181.01B | -17.17%96.85B | 2.40%174.68B | 29.02%116.92B | 0.80%170.58B | 46.43%90.63B | 32.89%169.22B | -14.96%61.89B | -6.57%127.34B |
| Cash on investment | -18.60%-117.81B | -10.31%-182.72B | 1.92%-99.34B | -10.97%-165.64B | -17.93%-101.28B | 14.35%-149.27B | -27.99%-85.88B | -42.11%-174.29B | 5.03%-67.1B | 16.78%-122.65B |
| Other items in the investment business | -115.80%-25.89M | ---- | 101.98%163.87M | ---- | -20,877.77%-8.27B | ---- | -61.02%39.81M | ---- | -96.24%102.14M | -63.91%13.33M |
| Net cash from investment operations | -2,082.96%-51.45B | -100.72%-126.97M | -85.87%2.59B | -50.56%17.59B | 177.55%18.37B | 6,725.28%35.58B | 446.67%6.62B | -187.66%-536.96M | -272.85%-1.91B | 104.93%612.52M |
| Net cash before financing | -378.20%-36.84B | -2.38%26.76B | -60.50%13.24B | -26.59%27.41B | 129.70%33.53B | 1,067.76%37.34B | 594.75%14.6B | -140.61%-3.86B | -128.77%-2.95B | 306.39%9.5B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 3.84%89.3B | 31.67%165.54B | 65.30%86B | 21.40%125.72B | -37.78%52.03B | -25.04%103.56B | -10.82%83.61B | 8.27%138.16B | 16.22%93.76B | 4.55%127.61B |
| Refund | -18.49%-85.05B | -12.06%-156.96B | -21.03%-71.78B | -8.84%-140.07B | 9.16%-59.31B | -1.10%-128.7B | 16.56%-65.29B | -17.05%-127.3B | -30.65%-78.25B | 1.66%-108.75B |
| Interest paid - financing | -6.50%-6.48B | 4.11%-12.28B | -1.67%-6.08B | -4.93%-12.81B | -1.69%-5.98B | -11.53%-12.21B | -11.21%-5.88B | -3.92%-10.94B | -3.78%-5.29B | -2.47%-10.53B |
| Dividends paid - financing | -1,438.15%-174.12M | -602.45%-251.73M | ---11.32M | 98.98%-35.84M | ---- | -272.87%-3.51B | ---1.64B | 36.63%-942.43M | ---- | 32.60%-1.49B |
| Absorb investment income | -18.91%763.79M | 59.36%1.39B | 342.42%941.88M | -84.89%869.71M | -27.42%212.89M | 48.75%5.76B | -65.99%293.33M | -17.57%3.87B | 111.66%862.38M | 21.02%4.69B |
| Issuance expenses and redemption of securities expenses | 7.51%-116.64M | 7.30%-167.26M | -81.67%-126.1M | 66.83%-180.43M | -418.35%-69.41M | 49.70%-543.94M | 97.62%-13.39M | -1.79%-1.08B | -66.34%-562.59M | -659.78%-1.06B |
| Other items of the financing business | -42.71%-4.39B | 18.87%-7.6B | 51.45%-3.07B | -3,818.81%-9.37B | -184.78%-6.33B | 108.97%251.9M | 5.47%-2.22B | 52.08%-2.81B | 39.45%-2.35B | -11.04%-5.86B |
| Net cash from financing operations | -315.00%-8.15B | 64.03%-14.27B | 117.91%3.79B | -4.05%-39.67B | -388.35%-21.18B | -942.05%-38.12B | 9.31%7.34B | -259.55%-3.66B | -36.52%6.72B | 148.23%2.29B |
| Effect of rate | --6.95B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -364.13%-45B | 201.91%12.49B | 37.94%17.04B | -1,462.54%-12.25B | -43.71%12.35B | 89.57%-784.3M | 482.20%21.94B | -163.74%-7.52B | -81.92%3.77B | 226.04%11.79B |
| Begining period cash | 17.06%85.71B | -14.34%73.22B | -14.34%73.22B | -0.91%85.47B | -0.91%85.47B | -8.02%86.26B | -8.02%86.26B | 14.38%93.77B | 14.39%93.77B | -10.24%81.98B |
| Cash at the end | -47.19%47.66B | 17.06%85.71B | -7.74%90.25B | -14.34%73.22B | -9.59%97.82B | -0.91%85.47B | 10.92%108.2B | -8.02%86.26B | -5.13%97.54B | 14.39%93.77B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.